The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4510-4515

  Schuller, Hildegard M ^a   Tithof, Patricia K ^a   Williams, Michelle ^a   Plummer III, Howard ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA SYNTHESIS; FATTY ACID TRANSPORT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RADIORECEPTOR ASSAY; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033568544     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics 1997. CA Cancer J. Clin., 47: 5-23, 1997.
2. Kane, M. A., and Bunn, P. A., Jr. Overview of the biology of lung cancer. In: M. A. Kane and P. A. Bunn, Jr. (eds.), Lung Biology in Health and Disease: Biology of Lung Cancer, Vol. 122, pp. 1-10. New York: Marcel Dekker, 1998.
3. Hoffmann, D., Djordjevich, M. V., and Hoffmann, I. The changing cigarette. Prev. Med., 26: 427-434, 1997.
4. Wynder, E. L., and Hoffmann, D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res., 54: 5284-5295, 1995.
5. Hecht, S. S., and Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (Lond.), 9: 875-884, 1988.
6. Hoffmann, D., Rivenson, A., Murphy, S. E., Chung, F. L., Amin, S., and Hecht, S. S. Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived N-nitrosamines. J. Smoking Relat. Disorders, 4: 165-190, 1993.
7. Rhodenius, S., vande Welering, M. L., Mooi, W. J., Evers, S. G., van Zandwijk, N., and Bos, J. L. Mutational activation of the K-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med., 317: 929-935, 1987.
8. Rhodenius, S., Slebos, R. J. C., Boot, A. J. M., Evers, S. G., Mooi, W. J., Wagenaar, S. S., van Bodegom, P. C., and Bos, J. L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res., 48: 5738-5741, 1988.
9. Belinsky, A., Devereux, T. R., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. The relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res., 40: 5305-5311, 1989.
10. 6-methyylguanine formation in Clara cells and induction of pulmonary neoptasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 50: 3727-3780, 1990.
11. Hecht, S. S. Recent studies on the mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. CRC Crit. Rev. Toxicol., 26: 163-181, 1996.
12. Starutz, M. E., Foiles, P. G., Miglietta, L. M., and Hecht, S. S. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenylethyl isothiocyanates. Cancer Res., 57: 259-266, 1997.
13. Park, P. G., Merryman, J., and Schuller, H. M. β-Adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. Cancer Res., 55: 3504-3508, 1995.
14. Rioux, N, and Castonguay, A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis (Lond.), 19: 1393-1400, 1998.
15. Castonguay, A., and Rioux, N. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis (Lond.), 18: 491-496, 1997.
16. Rioux, N., and Castonguay, A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res., 58: 5354-5360, 1998.
17. Wolf, H., Saukkonen, K., Anttila, S., Karjaleinen, A., Vainio, H., and Ristikami, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
18. Ruffolo, R. R., Bondinelli, W., and Hieble, J. P. α- and β-Adrenoreceptors: From the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J. Med. Chem., 38: 3681-3716, 1995.
19. Barbes, P. J. β-Adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med., 152: 838-860, 1995.
20. Borsa, E. S., Tenenbaum, A., Sales, M. E., Rumi, L., and Sterin-Borda, L. Role of arachidonic acid metabolites in the action of a β adrenergic agonist on human monocytes. Prostaglandins Leukotrienes Essent. Fatty Acids, 58: 85-90, 1998.
21. Ruan, Y., Kan, H., and Maliki, K. U. β-Adrenergic receptor stimulated prostacylin synthesis in rabbit coronary epithelial cells is mediated by selective activation of phospholipase D: inhibition by adenosine 3′5′-cyclic monophosphate. J. Pharmacol. Exp. Ther., 281: 1038-1046, 1997.
22. Schrör, K., Zimmermann, K. C., and Tannhäuser, R. Augmented myocardial ischemia by nicotine: mechanisms and their possible significance. Br. J. Pharmacol., 125: 79-86, 1998.
23. Blobe, G. C., Khan, W. A., and Hannum, Y. A. Protein kinase C: cellular target of the second messenger arachidonic acid. Prostaglandins Leukotrienes Essent. Fatty Acids, 52: 129-135, 1995.
24. Rao, G., Baas, A., Glasgow, W., Eling, T., Runge, M., and Alexander, R. Activation of mitogen-aclivated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem., 269: 32586-32591, 1994.
25. 2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J. Biol. Chem., 272: 30504-30511, 1997.
26. Chahn T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.
27. Smith, W. L. Prostanoid synthesis and mechanisms of action. Am. J. Physiol., 263: F181-F191, 1992.
28. Goetzl, E. J., An, S., and Smith, W. L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human disease. FASEB J., 9: 1051-1058, 1995.
29. 1-adrenoreceptors: sequence corrections and direct comparisons with other species homologues. J. Pharmacol. Exp. Ther., 272: 134-142, 1995.
30. Hulme, E. C. Receptor binding studies. In: E. C. Hulme (ed.), Receptor Biochemistry, pp. 303-315. Oxford: Oxford University Press, 1990.
31. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
32. Talmadge, J., Scott, R., Castelli, P., Newman-Tarr, T., and Lee, J. Molecular pharmacology of the β-adrenergic receptor on THP-1 cells. Int. J. Immunopharmacol., 15: 219-228, 1993.
33. 125I]-iodocyanopindolol. J. Recept. Res., 9: 495-508, 1989.
34. McPherson, G. A. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods, 14: 213-228, 1985.
35. MacDonald, R. J., Swift, G. H., Przybyla, A. E., and Chirgwin, J. M. Isolation of RNA using guanidinium salts. Methods Enzymol., 152: 219-227, 1987.
36. Fujii, N., Shibata, T., Homma, S., Ikegami, H., Murakami, K., and Miyazaki, H. Exercise-induced changes in β-adrenergic-receptor mRNA level measured by competitive RT-PCR. J. Appl. Physiol., 82: 1926-1931, 1997.
37. 1-adrenergic receptors. J. Mol. Cell. Cardiol., 27: 437-452, 1995.
38. 2 regulate the release of arachidonic acid for eicosanoid production and superoxide anion generation in neutrophils. J. Immunol., 160: 954-960, 1998.
39. Luttrell, L. M., Ferguson, S. S. G., Dauka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F-T., Kawakatsu, H., Owada, K., Luttrell, D. K., Caron, M. G., and Lefkowitz, R. J. β-Arrestin-dependent formation of β2 adrenergic receptor-src protein kinase complexes. Science (Washington DC), 283: 655-661, 1999.
40. Smith, T. J., Stoner, G. D., and Yang, C. S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochrome P450, lipoxygenase, and hydroperoxides. Cancer Res., 55: 5566-5573, 1995.
41. Hoffman, B. B., and Lefkowitz, R. J. Adrenergic receptor antagonists. In: A. Godman Gilman, T. W. Rall, A. S. Nies, and P. Taylor (eds.), The Pharmacological Basis of Therapeutics, pp. 221-243. New York: Pergamon Press, 1990.
42. Bondjers, G. Anti-atherosclerotic effects of β-blockers. Eur. Heart J., 15 (Suppl. C): 8-15, 1994.
43. Burris, J. F. β-Blockers, dyslipidemia, and coronary heart disease. Arch. Intern. Med., 153: 2085-2092, 1993.
44. Gutstein, D. E., and Valentin, F. Pathophysiological basis for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction. Clin. Cardiol., 21: 161-168, 1998.
45. United States Office on Smoking and Health. The Health Consequences of Smoking: Cardiovascular Diseases. A Report of the Surgeon General, pp. 179-203. Washington, DC: United States Government Printing Office, 1989.
46. Howard, G., Wagenknecht, L. E., Burke, G. L., Diez-Roux, A., Evans, G. W., McGovern, P., Nieto, J., and Tell, G. S. Cigarette smoking and the progression of atherosclerosis. J. Am. Med. Assoc., 279: 119-124, 1998.
47. Krüger, C., Hayenstetter, A., Gerber, S. T., Serf, C. H., Kaufmann, A., Kübler, W., and Haass, M. Nicotine-induced exocytic norepinephrine release in guinea-pig heart, human atrium, and bovine adrenal medulla cells: modulation by single components of ischemia. J. Mol. Cardiol., 27: 1491-1506, 1995.
48. Fisher, S., Spiegelhalder, B., Eisenbarth, J., and Preussmann, R. Investigation on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis (Lond.), 11: 723-730, 1990.